Connect with us

Hi, what are you looking for?

Health

Flu Season 2026-2027: How Should Clinicians Talk to Black Patients About Vaccines?

As the 2026–27 flu season approaches, clinicians caring for Black patients can address persistent disparities in influenza vaccination while ensuring patients understand their options.

By Audra Neale
BlackDoctor Pro
https://blackdoctor.pro/

As the 2026–27 flu season approaches, clinicians caring for Black patients can address persistent disparities in influenza vaccination while ensuring patients understand their options. According to the Centers for Disease Control and Prevention (CDC), during the 2025–26 flu season, 38 percent of non-Hispanic Black Americans aged 6 months and older received a flu vaccine, compared with 45.6 percent of non-Hispanic white Americans. That gap matters because influenza can cause serious health complications, particularly for people with chronic conditions or compromised immune systems.

For clinicians, closing that gap means more than myth-busting among Black patients. After all, Black Americans are not a monolithic group, and their individual decisions may reflect very different experiences, including misinformation, practical barriers to care, or concerns shaped by older vaccine formulations. Effective physician-led conversations can acknowledge valid concerns and ensure more people understand their health care prevention options.

Julie Myers, MD, MPH, Deputy Chief Medical Officer at MetroPlusHealth in New York City, recommends focusing on the personal benefits of vaccination. “While vaccine effectiveness can vary year to year, recent studies show that flu vaccination consistently reduces the risk of flu illness by between 30 percent and 60 percent,” she said. Physicians can use honest, proactive communication to acknowledge legitimate fears, explain options, and make vaccination more accessible to those who need it.

3 Flu Vaccine Facts That Physicians Should Lead With

1. There Is More Than One Type of Flu Vaccine

Patients today may think of flu vaccination as the same as the flu shot. In fact, calling it the flu shot is a misnomer because many vaccine types are available, and not all are injections. 

Currently, the U.S. seasonal vaccine market offers seven different types of flu vaccine. All target three influenza virus components, though products differ in how and where they are manufactured, how they are administered, and ideal patient demographics.

  • Adjuvanted vaccines (Fluad): Standard-dose inactivated shots containing an adjuvant (MF59) to help create a stronger immune response. Recommended for adults 65+. 
  • Cell-based vaccines (Flucelvax): Egg-free; Grown in mammalian cell culture instead of chicken eggs. Approved for individuals 6 months+. 
  • High-dose vaccines (Fluzone High-Dose): Contain four times the antigen of a standard-dose shot to induce a strong immune response in older adults. Recommended for adults 65+. 
  • Live attenuated nasal spray (FluMist): Made with weakened (live attenuated) viruses and delivered as a nasal spray rather than a shot. Approved for ages 2 through 49; not recommended for pregnant women or immunocompromised people.
  • mRNA flu vaccine (mFLUSIVA): The first FDA-approved mRNA flu injection, approved for adults 50 and older.
  • Recombinant vaccines (Flublok): Produced synthetically using a recombinant gene technology without flu viruses or eggs, containing three times the antigen of a standard shot. It is approved for ages 9+.
  • Standard-dose inactivated shots (Afluria): Grown in eggs; can be given by standard needle (ages 6 months+) or a needle-free injector (ages 18-64).

Clinicians should consult current CDC recommendations before recommending a specific product. That said, many patients appreciate providers who explain the choices, including pros and cons. That simple step can improve patient uptake.

2. The Flu Vaccine Rarely Ever Gives Patients Influenza

Some patients experience fatigue, muscle aches, headache, or a low-grade fever after vaccination and assume they caught the flu. Clinicians can explain that side effects are not the same as catching the real influenza virus.

Injectable inactivated vaccines do not contain live influenza viruses capable of causing flu illness. Dr. Myers reminds us that the live-virus vaccine is the only one delivered through a nasal spray, so getting sick from it is extremely rare. While side effects can occur and vaccination does not guarantee immunity from infection, vaccines can reduce the risk of serious complications.

Advertisement. Scroll to continue reading.

Conspiracy theories and misinformation should be corrected with clear evidence, not ridicule. If a patient believes a flu vaccine will make them sick, explain how the formulation works and distinguish expected side effects from symptoms of infection. If the patient describes a previous reaction, ask what happened and when, rather than assuming the concern is false. New vaccines use data and technology to reduce some common side effects of older vaccine formulations. If the patient’s last flu shot was over a decade ago, physicians should be patient when explaining how much medical science has changed since then.

3. An Egg Allergy Is No Reason to Skip Flu Vaccination

This distinction matters when discussing vaccine safety with people who have food allergies. Earlier flu vaccines were commonly produced using chicken eggs, leaving trace amounts of egg protein in some products. Under older recommendations, people with severe egg allergies had reasons to be concerned. These concerns were not simply imaginary. 

For physicians treating Black patients, it is imperative to know that studies have shown that Black children are twice as likely to have peanut, egg, and dairy allergies when compared to white peers. And yet, people of color experience many challenges in getting properly diagnosed and treated, and children may especially face negative psychosocial consequences like isolation and anxiety.

This means physicians should take self-reported allergies seriously and go the extra mile if a patient says they suspect an underlying allergy but aren’t quite sure. There are no-egg based flu vaccine options, but this conversation could also be a gateway to further referrals to specialists who might help a patient track down the root causes of what might have been a prior poor reaction to an egg-based vaccine formulation. The CDC’s current egg-allergy guidance is relevant.

In patient-care settings, acknowledge why someone may have heard older advice or harbor fears, explain what has changed, and offer a current recommendation based on the patient’s actual history. 

Photo by FG Trade/Getty Images

Easy Ways That Physicians Can Explain Available Vaccine Options

Rather than listing every brand, clinicians can organize the choices around three questions: Does the patient need an injection or prefer a nasal spray? Is there a medical reason to avoid a live vaccine? Does the patient’s age make an enhanced formulation preferable?

For most patients, an age-appropriate shot is suitable. FluMist may be an option for healthy, non-pregnant people, but it is not appropriate for everyone, including people with immunosuppression. Patients receiving chemotherapy or other immunosuppressive treatment may also need individualized guidance about vaccine selection and timing.

A concise explanation of the choices can help patients understand that vaccine choice is not a zero-sum game. The best option depends on age, health status, contraindications, preferences, and local availability. 

Advertisement. Scroll to continue reading.

Why No-Needle Options Matter

For patients who hate needles, have sensory sensitivities, or have had previous difficult experiences, a nasal spray may be a great option. This method offers practical advantages for people with mobility limitations, caregiving responsibilities, transportation barriers, or difficulty getting to a care provider.  

The FDA approved FluMist back in 2003, but the at-home option just started last flu season. The FDA’s announcement describes it as the first influenza vaccine approved for administration by the recipient or a caregiver. Eligible patients can check the FluMist Home program for screening, delivery requirements, and availability.

FluMist is approved for people aged 2-49, so clinicians should be clear that this option is not suitable for everyone. Patients who cannot use the nasal spray but want to avoid a conventional needle poke may ask for a jet injector instead. The jet injector is a skin-delivery option limited to certain products and age groups. These methods are less common requests, so clinicians can direct U.S. patients to Vaccines.gov to locate vaccination services and to confirm that a particular formulation is in stock.

Why Immune Health Makes Flu Vaccination Especially Important 

Clinicians should give particular attention to patients whose health conditions or treatments increase their risk of serious influenza complications. Black Americans are disproportionately affected by HIV, making it important for clinicians to incorporate routine prevention into ongoing HIV care without making assumptions about any individual’s diagnosis.

People living with HIV have a higher risk of serious flu complications, particularly when their immune system is significantly weakened. Dr. Myers explained the clinical issue directly: “For example, people with HIV that has led to AIDS and a low CD4 count, have lower vaccine efficacy.” She also noted that immunosuppression can affect vaccine response more broadly. The CDC recommends an injectable flu vaccine for people with HIV, not the live attenuated nasal spray.

The same attention is important for patients receiving cancer treatment. Dr. Myers explained, “Since chemotherapy is a form of immunosuppression, this impacts the optimal timing of influenza vaccine with respect to initiation of chemotherapy if at all possible (i.e., influenza vaccination should precede chemotherapy initiation by 2 weeks).” She adds, “There is similar guidance around the timing of the vaccine relative to other forms of medication/therapy that cause immunosuppression.”

Timing must be coordinated with the treating clinician because certain treatments can reduce immune response. Vaccine recommendations have to account for the kinds of therapy involved. The CDC advises that people with compromised immunity receive an age-appropriate inactivated or recombinant vaccine rather than the live nasal spray. The guidance on influenza vaccination during immunosuppression can help.

Advertisement. Scroll to continue reading.

How Can Clinicians Encourage Patients to Explore Vaccine Options? 

First, ask what is driving the patient’s concern. Is it fear of needles, a previous reaction, a belief that the vaccine caused influenza, a history of egg allergy, or a practical barrier such as transportation? These concerns require different responses. Asking an open question lets clinicians address the real issue rather than assuming reluctance signals resistance.

Clinicians should also be prepared to distinguish a conspiracy theory from a concern rooted in a real but outdated experience. Clinicians should correct claims that vaccines contain tracking devices or are deliberately designed to cause illness. In contrast, a patient who remembers being warned about a severe egg allergy may be recalling guidance that genuinely existed. Acknowledging that history before explaining current recommendations can make the conversation more credible.

Dr. Myers said clinicians can model confidence in vaccination by sharing their own willingness to receive the vaccine and recommending it to friends and family.

Finally, clinicians should help patients decide what to do with all this new information. 

Culturally responsive care means listening without judgment, acknowledging the history behind a concern when relevant, and offering a practical path toward flu protection.

Affordability Does Not Guarantee Availability 

Clinicians should prepare patients for the practical reality of flu vaccination: insurance coverage does not guarantee that a specific vaccine formulation will be available nearby, immediately, or at the expected cost. This is especially important when discussing needle-free options, which remain relatively uncommon. They may be easier to find in areas with more pharmacies, clinics, and vaccination providers. Patients in rural areas, people with disabilities, and those who rely on others for transportation may face additional hurdles.

Without this expectation-setting conversation, patients may travel farther than expected, face delays, or find that their preferred option costs more than expected. These experiences can deepen frustration and discourage vaccination altogether. Being prepared for the realities can help willing patients follow through on their choice. 

Advertisement. Scroll to continue reading.

Encourage patients to check availability, insurance coverage, and any potential out-of-pocket costs before traveling to an appointment. Calling ahead is especially important for needle-free delivery methods. Online tools such as Vaccines.gov help patients locate vaccination providers, but patients should confirm directly that the specific product is in stock and that their insurance will cover it.

The goal is to set realistic expectations from the outset, reduce avoidable frustration, and help patients find a feasible way to get vaccinated.

We Must Address Growing Anti-Vaccine Sentiment, AAP rsv vaccine guidance

Key Takeaways

  • Address the vaccination gap head-on. Black patients have lower flu vaccination coverage than non-Hispanic white patients, but clinicians should not assume they know why. Instead, ask each patient about their specific concerns and share vaccination options that fit their needs. Be prepared to share data so patients can build confidence and learn more.
  • Put vaccine safety in context. Egg-allergy precautions were part of older guidance, but newer formulations allow people with egg allergies to get vaccinated safely. CDC guidance clearly outlines how to manage severe reactions and other food allergies. Patients may need help understanding that “the flu shot” has changed over time — the historical and technological context has changed.
  • Prioritize prevention for immunosuppressed patients. People with HIV and cancer should take special precautions to mitigate the risks of the flu. The patient’s care team can recommend appropriate vaccinations and coordinate the best timing.
ADVERTISEMENT

News Video

IMM Mask Promos

I Messenger Media Radio Shows

ADVERTISEMENT

Related Articles

News

For years, Texas Democrats dreamed of flipping seats in the longtime GOP stronghold of Texas.

News

Jackson Mayor John Horhn called for an end to personal attacks at City Hall after Ward 3 Councilman Kenneth Stokes directed a sexist slur...

News

DALLAS, – Soul Reborn, founded by national philanthropist, best-selling author, award-winning filmmaker, speaker and global media executive Dr. Cheryl Polote Williamson is celebrating 46...

Spotlight Story

Fried Hard Blvd brings big Louisiana flavor to Dallas with its mouthwatering selection of crispy, well-seasoned fried fish, wings, and Cajun comfort food

Advertisement